RYCXX:NASDAQ
Rydex Series Funds – RYCXX Fund Overview
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|
| 1.00 | 0.00 (0.00%) | 1.00 - 1.00 | -- |
Market data as of --. Quotes are delayed by at least 15 min.
Overview - RYCXX
Growth of $10,000 (10 Years)
| Total Return | -- |
|---|
| Yield (Trailing 12 Mo.) | -- |
|---|
| Expense Ratio | -- |
|---|
| Front Load | None |
|---|
| Deferred Load | None |
|---|
| Minimum Investment | -- |
|---|
| Management Tenure | -- |
|---|
| Fund Inception | -- |
|---|
Trailing Total Returns - RYCXX
as of --
| Timeframe | RYCXX | S&P 500 | |
|---|
| 1 Month | -- | -5.63% | -- |
|---|
| 3 Month | -- | -4.27% | -- |
|---|
| Year-to-Date | -- | -4.27% | -- |
|---|
| 1 Year | -- | 8.25% | -- |
|---|
| 3 Year | -- | 9.06% | -- |
|---|
| 5 Year | -- | 18.59% | -- |
|---|
| 10 Year | -- | 12.50% | -- |
|---|
| Since Inception | -- | 10.98% | -- |
|---|
Sector Allocation - RYCXX
as of --
| Basic Materials | | -- |
|---|
| Consumer Cyclical | | -- |
|---|
| Financial Services | | -- |
|---|
| Real Estate | | -- |
|---|
| Consumer Defensive | | -- |
|---|
| Healthcare | | -- |
|---|
| Utilities | | -- |
|---|
| Communication Services | | -- |
|---|
| Energy | | -- |
|---|
| Industrials | | -- |
|---|
| Technology | | -- |
|---|
Asset Allocation - RYCXX
as of --
| By Percent | Short | 0% | Long | Net |
|---|
| Stock | -- | | | -- | -- |
|---|
| Bond | -- | | | -- | -- |
|---|
| Other | -- | | | -- | -- |
|---|
| Foreign Stock | -- | | | -- | -- |
|---|
| Foreign Bond | -- | | | -- | -- |
|---|
| Total | -- | | | -- | -- |
|---|
| Cash | -- | | | -- | -- |
|---|
| Total Net Assets | -- |
|---|
| Total Stock Holdings | |
|---|
| Total Bond Holdings | |
|---|
Top Ten Holdings - RYCXX
as of --
| Company | YTD Return | % of Assets |
|---|
Valuation & Growth - RYCXX
as of --
| Valuation | RYCXX | Category Range |
|---|
| Price/Earnings | -- | |
|---|
| Price/Book | -- | |
|---|
| Price/Sales | -- | |
|---|
| Price/Cash Flow | -- | |
|---|
| Dividend Yield | | |
|---|
| LT Earnings | | |
|---|
| Historical Earnings | | |
|---|
| Sales Growth | | |
|---|
| Cash-Flow Growth | | |
|---|
| Book-Value Growth | | |
|---|
